Coumarins represent an important class of phenolic compounds with multiple biological activities, including inhibition of lipidic peroxidation and neutrophil-dependent anion superoxide generation, anti-inflammatory and immunosuppressor actions. All of these proprieties are essential for that a drug may be used in the treatment of inflammatory bowel disease. The present study examined intestinal anti-inflammatory activity of coumarin and its derivative, the 4-hydroxycoumarin on experimental ulcerative colitis in rats. This was performed in two different experimental settings, i.e. when the colonic mucosa is intact or when the mucosa is in process of recovery after an initial insult. The results obtained revealed that the coumarin and 4-hydroxycoumarin, at doses of 5 and 25 mg/kg, significantly attenuated the colonic damage induced by trinitrobenzenesulphonic acid (TNBS) in both situations, as evidenced macroscopically, microscopically and biochemically. This effect was related to an improvement in the colonic oxidative status, since coumarin and 4-hydroxycoumarin prevented the glutathione depletion that occurred as a consequence of the colonic inflammation.
Inflammatory bowel diseases (IBD) refer essentially two different but closely related conditions, ulcerative colitis and Crohn's disease. These disorders are characterized by increase influx of neutrophils and increased production of inflammatory mediators. 1) Although IBD etiology is poorly understood, there is evidence that is involves immune, genetic and environmental factors, which is related to the initiation and progression of colitis. 2, 3) These are probably related to an abnormal exacerbated immune response to otherwise innocuous stimuli which is not properly abrogated by the feedback system that normally downregulates the mucosa response to luminal factors. 4) As a consequence, increased numbers of inflammatory cells are found in areas of intestine with chronic inflammation, resulting in an overproduction of variety of proinflammatory mediators, such as eicosanoids, platelet activating factor, cytokines and reactive oxygen and nitrogen metabolites. [1] [2] [3] [4] [5] The oxidative stress through an excessive release of reactive oxygen species (ROS) has been proposed to play a key role in IBD pathogenesis. 6, 7) Considering this, the use of antioxidant compounds may be useful in limiting damage in IBD. In fact, it has been proposed that antioxidant activity may be responsible for the beneficial effects showed by 5-aminosalycilate derivatives in human IBD. 8) The actual therapeutic treatments of IBD include drugs, such as 5-aminosalicylic acid derivates, systemic or local glucocorticoids and anti-TNF agents that exert beneficial effects through a combination of different mechanisms which result in the down-regulation of the exacerbated immune response that characterizes these diseases. However, the characteristics of this inflammatory process imply the use of these drugs during prolonged time periods, and unfortunately, these drugs are not devoid of potentially serious side effects which limit their use. 9) For this reason, the development of new drug treatments that combine efficacy and safety is an important goal in IBD therapy.
Previous studies have shown the beneficial effects of different antioxidant compounds in experimental models of rat colitis, including flavonoids like quercitrin, rutoside, morin, diosmin and hesperidin, 10) vitamin E 11) and tempol. 12) Recently, a natural antioxidant isocoumarin displaying chemical features similar those of flavonoids has been its protective effects described in a model of rat colitis. 13) In fact, similarly to flavonoids and isocoumarin, several coumarins showed antioxidant activity and represents a potential active compounds class for IBD prevention or treatment, but none studies with these compounds were performed in experimental models of colitis. The coumarins (also known as benzopyrones) consist of fused benzene and a-pyrone rings and form a large class of phenolic compounds. It is present in plants, fungi and bacteria, 14) and has been reported to have many biological activities without evidence of toxicity, 15) including reduction of tissue oedema and inflammation. 16) In addition, coumarin and two of its mono-hydroxylated derivatives (4-hydroxycoumarin and 7-hydroxycoumarin) inhibit prostaglandin biosynthesis. 17) Considering the data above, it is plausible that the coumarin and its derivative, the 4-hydroxycoumarin, may be helpful in intestinal diseases treatment due its anti-inflammatory action. This prompted us to investigate the effects of coumarin and 4-hydroxycoumarin in the experimental model of rat colitis induced by trinitrobenzenesulphonic acid (TNBS), a rat model of intestinal inflammation that has some histological and biochemical features of the human disease. 18) For this purpose, we assayed the effects of coumarin and its derivative 4-hydroxycoumarin in preventing the acute inflammatory response induced by TNBS in two different experimental setting, i.e. when the colonic mucosa is intact or when the mucosa is healing after an initial insult. 
Intestinal Anti-inflammatory Activity of Coumarin and 4-Hydroxycoumarin in the Trinitrobenzenesulphonic

MATERIALS AND METHODS
Drugs Preparation
Coumarin and 4-hydroxycoumarin ( Fig. 1 ) and sulphasalazine were provided by Sigma Chemical and suspended in sunflower oil. It was prepared freshly each time for animal administration.
Animals Male Wistar rats (180-200 g) obtained from the Laboratory Animal Service of the São Paulo State University (UNESP-Botucatu) were housed in makrolon cages (4 rats per cage) and maintained in air-conditioned animal quarters with a 12 h light-dark cycle and air-filtration. Animals had free access to water and food (Bio Base). The study was carried out in accordance with "Guide for the care and use of laboratory animals" as promulgated by the Animal Experimental Committee of the São Paulo State University.
Experimental Design Colitis was induced by the method originally described by Morris et al. 18) Animals were fasted overnight and anaesthetized with halothane. Under anesthesia, they were given 10 mg of TNBS dissolved in 0.25 ml 50% ethanol (v/v) by means of a Teflon cannula inserted 8 cm through the anus. Rats form the non-colitic (normal) group received 0.25 ml of phosphate buffered saline. Two different protocols were followed:
Acute Colitis: Rats were given 2.5, 5, 10, 25 and 50 mg/kg per day of coumarin, 5, 10, 25 and 50 mg/kg per day of 4-hydroxycoumarin orally and 25 mg/kg per day of sulphasalazine for 3 d before colitis induction as well as 2 and 24 h thereafter. Coumarin, 4-hydroxycoumarin and sulphasalazine were administered by means of an esophageal catheter (volume: 5 ml/kg). Rats from non-colitic and nontreated colitic groups (TNBS-control group) were orally administered with vehicle. Animals from all groups (nϭ8) were killed 48 h after colitis induction by an overdose of halothane.
Colitis Relapse: In this protocol, colitis was firstly induced with 10 mg of TNBS in 50% ethanol, as described previously, and after 14 d animals were given a second dose of 10 mg of TNBS in an attempt to mimic the relapses common in human IBD. The animals were divided in six groups; four groups were daily orally treated with 5 or 25 mg/kg of coumarin or 4-hydroxycoumarin dissolved in sunflower oil, one group received instead 25 mg/kg of sulphasalazine suspended in the same vehicle, where as the remaining group received vehicle (5 ml/kg sunflower oil). Treatments started 2 h after the first administration of TNBS and continued until the day before the animals were killed. Two additional groups were included for reference: a non-colitic group and a colitic group, receiving the latter only the first dose of TNBS (TNBS-control group without relapse), both groups were given the vehicle (5 ml/kg sunflower oil) orally. Animals from each group (nϭ8) were sacrificed after 1, 2 or 3 weeks of the colitis induction, whereas all animals from the colitic control group without relapse were sacrificed after 3 weeks.
Assessment of Colonic Damage Animal body weights, occurrence of diarrhea (as detected by perianal fur soiling) and total food intake for each group were recorded daily. The animals were euthanized by an overdose of halothane, the colonic segments were obtained after laparotomy and the eventual occurrence of adhesions between the colon and adjacent organs was noted. They were placed on an ice-cold plate, cleaned of fat and mesentery, and blotted on filter paper, and the colon was weighed and its length measured under a constant load (2 g). The colon was longitudinally opened and scored for macroscopically visible damage on a 0-10 scale by two observers unaware of the treatment, according to the criteria described by Bell et al. 19) ( Table 1 ). The colon was subsequently divided longitudinally into different pieces to be used for the biochemical determinations: myeloperoxidase (MPO) activity, alkaline phosphatase (AP) activity and total glutathione (GSH) content.
MPO activity was measured according to the technique described by Krawisz et al. 20) Samples were suspended in 1 ml of 50 mM phosphate buffer incorporating 0.5% hexadecyltrimethylammonium bromide (pHϭ6.0), and minced with scissors for 15 s on ice-cold plate. The resultant suspension was subsequently diluted to a final 1 : 20 w/v ratio and homogenized for 1 min with an automatic Heidolph homogenizer, sonicated for 10 s and subjected to three freeze-thaw cycles. The homogenates were then centrifuged at 7000 g and 4°C for 10 min, and the supernatants were assayed for MPO activity. The results are expressed as MPO units per gram of wet tissue.
AP activity was measured spectrophotometrically, using disodium nitrophenylphosphate (5.5 mM) as substrate in 50 mM glycine buffer with 0.5 mM MgCl 2 (pHϭ10.5). 21) Results are expressed as mU per milligram of protein.
Total GSH content was quantified with the recycling assay described by Anderson. 22) Samples were thawed, minced, diluted 1 : 20 (w/v) in ice-cold 5% (w/v) tricholoroacetic acid and homogenized. The homogenates were centrifuged at 7000 g for 15 min at 4°C, and the supernatants were used to quantify glutathione content. The results are expressed as Linear ulcer with inflammation at one site 4 Ն2 sites of ulceration/inflammation 5 Ն2 major sites of ulceration and inflammation or one site of ulceration/inflammation extending Ͼ1 cm along the length of the colon 6-10
If damage covers Ͼ2 cm along the length of the colon, the score is increased by 1 for each additional centimeter of involvement nanomoles per gram wet tissue. Additional in vitro experiments were performed in order to test the antioxidant activity of different concentrations of coumarin and 4-hydroxycoumarin (1-100 mM). This was evaluated by inhibition of induced lipid peroxidation in rat brain membrane, as described previously by Gálvez et al., 23) with some modifications. The flavonoid quercetin was used as reference and tested in the same assay system.
Histological Analysis In the acute colitis protocol, representative whole gut specimens were taken from a region 2 cm above the inflamed region of colon. The samples were fixed in ALFAC solution (80% alcohol, acetic acid and formaldehyde) for 24 h at 4°C. Then the samples were routinely processed for embedding in paraplast, cut into 7 mmthick sections and put into histological slides. These sections were stained with Hematoxylin-Eosin (HE). After staining, slides were analyzed and photomicrography with a Leica microscope, associated with Leica Qwin Software (Leica-England).
Statistics Analysis Results are expressed as meanϮ S.E.M. differences between means were testes for statistical significance using one-way analysis of variance (ANOVA) and post hoc least significance tests. Nonparametric data (score) are expressed as median (range) and were analyzed with the Mann-Whitney U test. Differences between proportions were analyzed with c 2 test. Statistical significance was set at pϽ0.05.
RESULTS
Acute Colitis
Intracolonic administration of TNBS resulted in colonic inflammation, which was evidenced after 48 h with severe necrosis of the mucosa, typically extending 1.98-4.90 cm along the colon, bowel wall thickening and hyperaemia (Table 2 ). This inflammatory process was associated to an increase of colonic weight/length ratio and to a reduction in food intake (data not shown) when compared to non-colitic rats and to signs of diarrhea in 80% of the colitic animals ( Table 2 ). In consequence, a significant reduction in body weight was observed in colitic animals (12.2Ϯ3.1% weight loss vs. 5.2Ϯ0.7% weight gain in non-colitic rats, pϽ0.05). The colonic damage was biochemically characterized by a 7-fold increase in colonic MPO activity, as an index of neutrophil infiltration, and by a 3-fold increase in phosphatase alkaline (AP) activity and significant colonic glutathione depletion (Table 3) , both as consequence of the oxidative stress that place in the inflamed colon.
Coumarin showed a beneficial preventative effect in colitic rats, as evidenced by reduction in the macroscopic damage score value in comparison with non treated colitic group at dose of 25 mg/kg (Table 2 ), but these effect was not related to counteract GSH content and, MPO and AP activities ( Table 3 ). However, it is important to note that coumarin at dose of 5 mg/kg was able to reduced extension of lesion and counteracted GSH content, as well as to reduced MPO and AP activities. In the same set of acute experiments, pre-treatment with 4-hydroxycoumarin at dose of 10 and 25 mg/kg reduced damage score and extension of lesion (Table 2) , as well as counteracted GSH content and reduced AP activity. In addition, pre-treatment with 5 mg/kg of 4-hydroxycoumarin produced significant effects on biochemical parameters, particularly reducing AP activity and counteracting GSH content (Table 3) . These results prompt us to select both doses for test in the chronic with relapse protocol. Coumarin (2.5, 50 mg/kg) and 4-hydroxycoumarin (50 mg/ kg) was ineffective. The histological studies confirmed the beneficial effect of coumarin and 4-hydroxycoumarin (Fig. 2) . In this effect, samples from colitic animals treated with 5 and 25 mg/kg of coumarin and 4-hydroxycoumarin showed an good recovery of the intestinal cytoarchitecture, characterized by a restoration of the epithelial cell layer accompanied by the presence of goblet cells in straight tubular gland and normal quantity number of cells.
Sulphasalazine treatment of colitic rats, at the dose of 25 mg/kg, showed a preventative effect in acute colitis evidenced by reduction of damage score and extension of lesion (Table 2 ). This effect was associated to a reduction in MPO and AP activities (Table 3 ). In addition, sulphasalazine treatment was able to counteract the glutathione depletion that occurs subsequently to the inflammation process (Table 3) .
Chronic Colitis The inflammatory process induced by intracolonic instillation of 10 mg of TNBS in 50% ethanol (v/v) progressed in time with similar characteristics those previously reported by Di Stasi et al. 13) Thus, the colonic damage was maximal at first week and decreased gradually over time during the following two weeks, although the colonic segments still appeared macroscopically ulcerated and inflamed, with a concomitant increase in the colonic weight/length ratio and extension of lesion (Table 4 ). The progress of the inflammatory process was also observed biochemically since MPO and AP activities were maximally increased 7 d after first TNBS instillation compared to non-colitic animals and decreased with the time (Table 5 ). These results were also associated by a significant reduction in colonic glutathione content evidenced in all weeks of evaluation (Table 5) .
Colitic relapse was induced with a second dose of 10 mg of TNBS in 50% ethanol intracolonically administered two weeks after first administration. One week after this second instillation of TNBS, a reactivation of the colonic inflammatory process was observed, as evidenced by a significant increase of the macroscopic damage score, extension of lesion and weight/length ratio (Table 4 ) when compared to the normal evolution of colonic damage in those animals that did not receive the second those of TNBS (control without relapse). Indeed, an alteration of the colonic absorptive function was noted since 75% of rats displayed evident signs of diarrhea, as opposed to those without relapse that had no diarrhea (Table 4) . Similarly, reactivation of the intestinal inflammatory process was associated with a colonic oxidative insult because glutathione content was also depleted in these animals when compared with animals without relapse ( Table   5) .
Administration of 5 mg/kg of coumarin to colitic animals reduced damage score and extension of lesion at the first and second weeks, but this treatment did not prevent the colitic animals from impact of the colitic relapse as evidenced macroscopically (Table 4) . On the other hand, both doses of coumarin were able to counteract GSH content at the third week (Table 5 ). In the same set of experiments, administration of 5 and 25 mg/kg of 4-hydroxycoumarin was able to reduce damage score and extension of lesion at the first and second week, as well as prevents colitic animals from impact of the colitic relapse (Table 4) . These effects were accompanied by counteraction of GSH content at the second and third weeks (Table 5) . In (1) observed numerous straight tubular gland (arrow) with a lot numbers of goblets cells, the lumen epithelium was intact at typical morphology. In (2) the tubular gland were minor with the narrowing of lumen and the goblets cells was not frequently in wall of gland, the mucosa of colon was dilated and there were many lymphocytes in lamina propria (arrow). In (3) the tubular gland (arrow) with normal dilation of lumen and the low numbers of goblets cells, and there were lymphocytes cells in lamina propria, but this area was small thus compared with TNBS-control group. In (4) the showed the little scale of lumen (#), the tubular glands (arrow) was intact with goblet cells, the lamina propria was normal. In (5) showed the intact epithelium, but the tubular glands (arrow) were disorganized and the absent of goblet cells. In (6) the mucosa showed the disrupt lumen epithelium and the thickness were reduced, the glands (arrow) were the straight but the goblets cells not occurs, submucosa was reduction of thickness. In (7) showed the conserved epithelium, with goblet cells in straight tubular gland (arrow) and normal quantity number of cells, the submucosa showed the severe edema. mϭmucosa and sϭsubmucosa.
Sulphasalazine treatment of colitic rats, at the dose of 25 mg/kg, also showed a preventative effect in the colitis relapse induced by the second administration of TNBS, evidenced by reduction of damage score and extension of lesion (Table 4) . Biochemically, sulphasalazine treatment was able to counteract the glutathione depletion that occurred one week after the second administration of TNBS; however, no significant modifications were observed on MPO and AP activities in comparison with the corresponding control animals ( Table 5 ). The in vitro antioxidant experiments performed showed that coumarin and 4-hydroxycoumarin did not exert a concentration-dependent inhibitory effect on the lipid peroxidation induced in rat liver membranes.
DISCUSSION
Colitis induced by intracolonic instillation of TNBS manifests many of the histological and clinical features of colonic inflammatory bowel disease. 18) This model of colonic ulceration and transmural inflammation of the mucosa 24) has been employed to study the pathogenesis of colonic inflammation and to investigate potential treatments of IBD.
The present study shows the preventative effect exerted by coumarin and 4-hydroxycoumarin in ameliorating the colonic insult induced after intracolonic administration of TNBS/ethanol to rats in two different experimental conditions. In the first approach, the preventative intestinal anti-inflammatory activity of coumarin (5, 25 mg/kg), 4-hydroxycoumarin (5, 10, 25 mg/kg) and sulphasalazine (25 mg/kg) was evidenced macroscopically by reducing the extent and severity of the colonic lesions in the acute phase of the inflammatory process induced by TNBS/ethanol. Oral administration of sulphasalazine and of coumarin did not decrease the colonic weight/length ratio. The lack of an effect on this ratio can be explained based on the severe and too extensive colonic damage induced by TNBS/ethanol, which is difficult to overcome by pharmacological treatment as has been previously suggested. 25) On the other hand, the preventative effect of 4-hydroxycoumarin (25 mg/kg) in the acute colitis was associated with decrease of the colonic weight/length ratio. The anti-inflammatory activity of coumarin (5, 25 mg/kg) and 4-hydroxycoumarin (50 mg/kg) in the acute colitis was also related to decrease of the incidence of diarrhoea, thus indicating a restoration of the absorptive ability of the colon which is profoundly altered as a consequence of the inflammatory process.
26) The sulphasalazine (25 mg/kg) did not decrease the incidence of diarrhoea from colitic animals, as demonstrate by Gálvez et al. 27) These beneficial effects of coumarin (5 mg/kg) and 4-hydroxycoumarin (25 mg/kg) were also confirmed biochemically by measurement of MPO activity in the damaged colon. MPO, an enzyme predominantly found in the azurophilics granules of neutrophils, is a biochemical marker of neutrophil infiltration, and its activity measurement has been widely used to detect intestinal inflammatory process. 28, 29) Reduction of this enzyme activity can be interpreted as a manifestation of the anti-inflammatory property of a given compound. 25) Colonic tissue MPO activity, markedly elevated in TNBS control animals, was significantly decreased in rats pretreated with coumarin (5 mg/kg) and 4-hydroxycoumarin (25 mg/kg), suggesting an anti-inflammatory activity of these coumarins.
Human IBD is characterized by an increased expression of markers of differentiation 30) and AP has been considered a phenotypic marker of differentiation, which is up-regulated, in experimental chronic diarrhea. 23) Moreover, the colonic tissue AP activity has been used to differentiate Crohn's disease from ulcerative colitis, because their AP enzymatic activity to be higher than Crohn's disease. 31) In the present study it was observed a higher AP activity in the colon from colitic animals compared to the non-colitic animals from acute intestinal inflammation model induced by TNBS/ ethanol, as well as demonstrated by Cruz et al. 32) The intestinal anti-inflammatory effect of coumarin (5, 50 mg/kg), 4-hydroxycoumarin (5, 10, 25 mg/kg) and sulphasalazine (25 mg/kg) was evidenced also by the significant reduction of the AP enzymatic activity compared to control animals.
Oxygen reactive species (ROS) have been proposed to play a key role in the pathophysiology of intestinal inflammation. 33) The main sources of reactive oxygen metabolites in the inflamed mucosa are activated phagocytic leukocytes, capable of producing superoxide and a cascade of various species leading to a very reactive hydroxyl radical and peroxide. The xanthine oxidase pathway in colonocytes also produces superoxide anion by conversion of xanthine/hypoxanthine to uric acid. A third possible source is the oxidation of arachidonic acid either through the lipooxygenase reaction, producing leukotrienes, or the prostaglandin generating cyclooxygenase reaction. 34) GSH plays a key role in controlling the redox state of the cell through several mechanisms, including scavenging of ROS and keeping the enzyme GSH peroxidase in a reduced state. 35) Decreased GSH levels, which are indicative of oxidant stress, have been detected in human 36) and experimental colitis. 13, 37, 38) Indeed, it has been reported that GSH supplementation improved oxidative damage in TNBS colitis. 39) Pretreatment with coumarin (5 mg/kg) and 4-hydroxycoumarin (5, 10, 25 mg/kg) in the acute phase of the inflammatory process induced by TNBS/ethanol, protected against colonic GSH depletion and restored the levels toward the normal value. This counteraction on colonic GSH depletion may be related to the action of these compounds as inhibitors of prostaglandin biosynthesis, 17) since one of the sources of production of free radicals is the oxidation of arachidonic acid either through the lipooxygenase or cyclooxygenase reactions.
34) The intestinal anti-inflammatory effect was evidenced microscopically, since treated rats showed a good preservation in the colonic cytoarchitecture compared to the corresponding control group.
In the acute phase of colonic inflammatory process, the protective effects of coumarin and 4-hydroxycoumarin were not dose-dependent. Several poliphenolic compounds, particularly flavonoids, also shown non dose-dependent response in TNBS model of rat colitis, probably due to produce in lower doses antioxidant effects and higher doses pro-oxidant effects. 13, 37, [40] [41] [42] In addition, several phenols have a dual effect on prostaglandin H synthase, with low concentrations stimulating and high concentrations inhibiting this enzyme. 43) Phenols stimulate prostaglandin H synthase by acting as reducing substrates for the oxidized intermediates of prostaglandin biosynthesis, thereby accelerating the peroxidase cycle and by functioning as electron-donating cosubstrates for the peroxidase component of prostaglandin synthase. Phenols inhibit the cyclooxygenase-2 activity by competing for the arachidonic acid-binding site and by competitive reduction of prostaglandin H synthase. 44) Since coumarins are poliphenolic compounds with important effects on oxidative stress and ulcerative colitis is mediated by reactive oxygen species, it is possible that these class of natural substances produces dual effects. On the other hand, inflammation is a multicomponent system that involves a network of cellular crosstalk and control. However, the anti-inflammatory effect produced by both coumarins will be re-lated to distinct mechanisms of action of these compounds on distinct inflammatory mediators.
The model of colitis by intracolonic instillation of TNBS has some limitations given that once TNBS has been administered intracolonical the inflammatory status resolves spontaneously with time until complete healing of the colonic mucosa, and this is not the situation in human IBD. However, Gálvez et al. 45) has reported a model of reactivated colitis similar to the protocol used in the present study.
The second intracolonic administration of TNBS effectively resulted in a reactivation of the colonic inflammatory response, as evidenced by the alteration in all the macroscopic and biochemical parameters of inflammation evaluated when compared with animals without relapse. The results demonstrated that oral administration of coumarin (5 mg/kg) after colitis induction significantly reduced macroscopic colonic damage score and extension of lesion at one and two weeks when compared to the corresponding TNBScontrol groups. Moreover, the treatment with 4-hydroxycoumarin was more effective than coumarin, since both the doses studied, reduced the macroscopic colonic damage score and the extension of lesion at one and two weeks and prevented the macroscopic damage caused by the second dose of TNBS, similar to oral administration of sulphasalazine. The oral administration of coumarin (5 mg/kg) did not prevent the macroscopic damage in the relapse induced by second dose of TNBS. These beneficial effects of 4-hydroxycoumarin (25 mg/kg) and sulphasalazine were associated with decreasing of the colonic weight/length ratio at one week. In addition, these compounds were able to alter the extent of neutrophil infiltration into the colon one week after TNBS administration, as determined by tissue MPO activity reduction. The reduction of neutrophil infiltration seemed to be a consequence of the accelerated healing of colonic ulcers, facilitating the elimination of neutrophil accumulation from the inflamed colon.
Similarly to the acute experimental setting, the anti-inflammatory effect exerted by coumarin and 4-hydroxycoumarin at doses of 5 and 25 mg/kg in chronic colitis was related to protective effect against GSH depletion, including in rats that undergo relapse. These results demonstrate that protection against oxidative insult may play a key role in the chronic anti-inflammatory activity of coumarin and 4-hydroxycoumarin.
In conclusion, coumarin and 4-hydroxycoumarin treatment partially prevents the colonic damage induced by TNBS in rats, both when the mucosa is intact and when the mucosa has been previously damaged and is in progress of recovery. This effect may be associated to an improvement on intestinal oxidative stress since treatments were able to inhibit glutathione depletion, but other pharmacological effects of coumarin and its derivative 4-hydroxycoumarin may be involved in this effect. Indeed, the presence of hydroxyl radical at C-4 in molecules of coumarin improves anti-inflammatory effect as evidenced by treatment of colitic animals with 4-hydroxycoumarin, in which produced beneficial effects when colonic mucosa was intact and when the mucosa is healing after initial insult, as well as prevented colitic animals from the impact of the colitic relapse.
